Practical steps for health systems facing FDA SaMD requirements, CMS conditions, and Joint Commission AI oversight mandates.
Healthcare systems are deploying AI at an unprecedented rate, from clinical decision support and diagnostic imaging to revenue cycle management and patient flow optimization. At the same time, regulatory bodies are establishing clear expectations for how these AI systems must be governed. The FDA's framework for Software as a Medical Device (SaMD), CMS conditions of participation, and Joint Commission standards are converging on a common requirement: healthcare organizations must demonstrate oversight, transparency, and accountability for every AI system that influences patient care.
For health system leaders, the question is no longer whether AI governance is necessary but how to implement it before enforcement actions begin. The organizations that build governance infrastructure now will avoid the costly disruption of retrofitting compliance onto AI systems that are already embedded in clinical workflows.
The FDA has established a risk-based framework for AI-enabled medical devices that requires predetermined change control plans, real-world performance monitoring, and documentation of algorithm modifications. Health systems using FDA-cleared AI tools must maintain records demonstrating that these tools are performing as intended and that any changes to the algorithms have been properly evaluated and documented.
CMS is incorporating AI oversight requirements into conditions of participation for hospitals and health systems. These requirements focus on ensuring that AI-assisted clinical decisions are subject to appropriate human oversight, that patients are informed when AI influences their care, and that organizations can demonstrate the accuracy and fairness of their AI systems across patient populations.
The Joint Commission has signaled its intent to evaluate AI governance as part of its accreditation surveys. Health systems should expect surveyors to ask about AI inventory, governance policies, performance monitoring, bias assessment, and clinical staff training on AI-assisted decision-making.
The health systems that will navigate AI governance most successfully are those that treat it as an operational priority rather than a compliance checkbox. By implementing decision integrity infrastructure through InferTrust™ (Patent Pending) and establishing governance processes now, health systems can ensure that every AI-assisted clinical decision is verifiable, traceable, and defensible when regulators come asking.